9/5/2012 Ricerca, cinque premi alla chimica

13/4/2012 6 maggio Giornata Nazionale per l’epilessia

20/3/2012 Cresset announces the opening of 4th Design a Molecule Competition

20/3/2012 Merck Serono is certified Top Employers 2012 in Italy

20/3/2012 "Il Decreto Liberalizzazioni: quale impatto sulla distribuzione dei medicinali?"

27/2/2012 Production of herbal extracts of high quality through the use of the Naviglio Estrattore®: The Company POLCARO Fitopreparazioni manifactures tinctures, extracts, oloeoliti.

25/2/2012 Injuries to the spinal cord: Presented at the Niguarda Hospital in Milan 'Lokomat', the robotic locomotion therapy equipment

25/2/2012 Rare Disease Day 2012 - February 29.

17/2/2012 A class of surgery: live TV from the operating room

6/2/2012 Boehringer Ingelheim Prolongates Drug Discovery Collaboration with Priaxon

6/2/2012 Customization of therapy for infertility

20/1/2012 Electricity for healing, between Positivism and Belle Epoque

11/1/2012 Merck Serono contributes to overcoming Schistosomiasis in Africa

11/1/2012 Thermo Fisher Scientific Creates New iPhone App for Selecting Bottles and Carboys

14/12/2011 VAXIMM Starts Clinical Study of First Oral Cancer Vaccine

12/12/2011 Cresset Launches Flexible Chemistry Service Program: CompChem on Demand

7/12/2011 New Molecular Diagnostic Test from Randox Enables Rapid, Appropriate Selection of Colorectal Cancer Patients for Anti-EGFR Therapy

7/12/2011 Recessive Loss-of-Function Mutation in the Pacemaker HCN2 Channel Causing Increased Neuronal Excitability in a Patient with Idiopathic Generalized Epilepsy

1/12/2011 Merck Serono: CHMP Gives Positive Opinion for Extended Indication

30/11/2011 A step forward to the identification of a drug treatment which could reduce the toxicity from exposure to high doses of radiation

25/11/2011 ATLAS FILTRI ENGINEERING presents the NAVIGLIO ESTRATTORE®

22/11/2011 The Italian Society of Preventive and Social Pediatrics approves the administration of the Intranasal Flu Vaccine in children.

18/11/2011 Prevent bacterial infections with the CD14 molecule

11/11/2011 Thermo Fisher Scientific Enables Easy HPLC Method Transitions

8/11/2011 Master's Degree in ECONOMICS AND MANAGEMENT OF HEALTH SERVICES

4/11/2011 Temperature control systems for research and production

3/11/2011 Domainex Awarded Technology Strategy Board Funding to Support its Research into a Novel Cancer Drug

2/11/2011 Cresset Announces Release of FieldStere Version 3.0

28/10/2011 Biotech Farmindustria: record investment in research

26/10/2011 Workshop

26/10/2011 XLII NATIONAL CONGRESS of The ITALIAN NEUROLOGY SOCIETY (SIN) ends in Turin

24/10/2011 Selvita presenta i risultati più recenti dai suoi programmi di Oncologia al Convegno ‘AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference’ 2011

24/10/2011 The seventh FARMAFFARI MARKETING PRIZE at NUCE 2011

17/10/2011 Merck Serono SpA: Antonio Messina is the new Chairman

17/10/2011 Merck Serono and Ono Pharmaceutical Form Collaborations to Develop Oral Multiple Sclerosis Drug and Cancer Immunotherapy

30/9/2011 Stratophase to Exhibit at BioTechnica 2011

28/9/2011 Soy May Not Reduce Menopausal Symptoms

28/9/2011 Merck Serono acquires the rights of the IP program for MS-2301

26/9/2011 Link Technologies Improves Oligonucleotides for Use in Research and Diagnostics

26/9/2011 The Marketing Award Farmaffari at Nuce International 2011

21/9/2011 Physical pain makes us feel excluded

16/9/2011 Thermo Fisher Scientific Introduces Gas Chromatography Columns

16/9/2011 The Olympus VS120 virtual slide system for digitising slides at high magnification

14/9/2011 Novel method for treating ovarian cancer

13/9/2011 Titian Software Mosaic presented at the 2011 MipTec European Drug Discovery conference and exhibition

29/8/2011 Prevention and control of tuberculosis (TB)

23/8/2011 The Italian League Against Epilepsy presents the 29th INTERNATIONAL EPILEPSY CONGRESS

27/6/2011 Unconventional medicine - University of Milano-Bicocca activates the first master's degree in Italy

27/6/2011 THIS SUMMER IN ITALY IS ON THE AIR THE CAMPAIGN OF PREVENTION OF AIDS PROMOTED BY ONLUS NPS

27/6/2011 Scientists discovered an entirely new way to change the genetic code. Altered RNA may help to develop treatments for genetic disorders

27/6/2011 The European Medicines Agency has recommended the approval of Eurartesim, from Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. for the treatment of malaria

9/6/2011 Antisense Pharma’s Trabedersen Showed Excellent Safety Profile and First Signals of Encouraging Efficacy in Solid Tumors

27/5/2011 Celebrated in a book, the centenary of the SIN - Italian Society of Neurology - Neurologists and Italians who have made the "history"

23/5/2011 INNOVATIVE THERAPY METHOD FOR THE TREATMENT OF BRAIN TUMORS

4/5/2011 EUROMELANOMA DAY 2011: MONDAY 'May 16 CAMPAIGN OF PREVENTION OF MELANOMA AND SKIN CANCER

2/5/2011 High Omega-3 Levels May Boost Cancer Risk

12/4/2011 New Life Science Awards Event and ELA 2011

6/4/2011 CT Atlantic AG to Present Positive Preclinical Results for NY-ESO-1 HD-MAB® at Forthcoming AACR Annual Meeting

6/4/2011 Research on pain, woman's suffering is less identifiable.

5/4/2011 34 ° NATIONAL CONGRESS OF ITALIAN LEAGUE AGAINST EPILEPSY

31/3/2011 Two hundred years after the birth of Robert Bunsen

31/3/2011 FDA Approves First Lupus Treatment in Half-Century

26/3/2011 Japanese Cloud arriving on the Italian skies

26/3/2011 The CRF included Merck Serono Institute among the top 32 Italian companies in Human Resource Management

26/3/2011 Chronic myeloid leukemia patients treated with imatinib have the same mortality rate among healthy people.

21/3/2011 TTP LabTech: Be In It, To Win It

21/3/2011 Syrris announce the launch of the easy-to-use Globe jacketed reactor platform.

21/3/2011 Mucosis Starts Clinical Study with its Lead Product, FluGEM™

16/3/2011 Tomorrow we celebrate the 150th anniversary of Italy’s Unity

16/3/2011 Annurca apple polyphenol extract showed chemopreventive properties in colorectal cancer cells.

14/3/2011 16th Annual Brain Awareness Week (BAW)

11/3/2011 New European Lab Automation Event Announced for 2011

25/2/2011 New Modular flow chemistry systems

21/2/2011 Towards a new remedy for baldness

18/2/2011 FDA monitoring 13 medications for potential adverse events risk.

16/2/2011 Thermo Fisher Scientific Introduces iPhone App to Simplify GC Column Selection

16/2/2011 Multiple Sclerosis (MS) and Pregnancy

16/2/2011 Progress in Computer-Assisted Diagnosis Tools to Aid Pathologists

14/2/2011 International Year of Chemistry – 2011

12/2/2011 Food Flavourings in the European Union

12/2/2011 New Dietary Guidelines in United States

10/2/2011 OGT expands CytoSure™ aCGH product range

10/2/2011 Thermo Fisher Scientific Inc. launched the new kit KingFisher for nuclei acids purification

4/2/2011 INAUGURATION OF THE COURSE 'GLOBAL HEALTH AND DEVELOPMENT'

3/12/2009 Alizé Pharma reveals promising data on Asparec(R) program for second-line ALL therapy

17/9/2009 “La vita del farmaco”, un congresso patrocinato dall’Unesco

17/9/2009 Il dolore cronico si ferma con gli zuccheri

8/9/2009 HDAC INHIBITORS MAY IMPROVE MEMORY IN ALZHEIMER’S PATIENTS

31/7/2009 Merck Serono is launching the Grant for Fertility Innovation (GFI)

27/7/2009 Funxional successfully completes initial clinical trial of FX125L, an anti-inflammatory drug with a novel mechanism of action

9/7/2009 ASCO 2009: PROMISING CLINICAL TRIALS FINDINGS ON PARP INHIBITORS

9/7/2009 Rapamycin for longer life?

7/7/2009 EMEA: SIGMA-TAU SUBMITS MARKETING AUTHORIZATION APPLICATION FOR THE NOVEL ANTI-MALARIAL EURARTESIM®

6/7/2009 VEGETARIANS HAVE LOWER CANCER RISK: A UK 12-YEAR STUDY

2/7/2009 Onglyza :A new oral hypoglycemic (anti-diabetic drug) DPP-4 inhibitors

1/7/2009 IPILIMUMAB. an immunotherapeutic agent called MDX-010 against the prostate cancer

29/6/2009 PARP Inhibitors Represent New Direction in Cancer Treatment

18/6/2009 The secret of the immune system in a molecule

15/6/2009 Successful phase II/III trial of new therapy for adrenal insufficiency

11/6/2009 A New Chemical Element in the Periodic Table

11/6/2009 Two-Year Data Show Investigational Drug Liraglutide More Effective at Lowering Blood Sugar Than Glimepiride

10/6/2009 Business Plan Competition at the World Conference on Regenerative Medicine organized by HHL – Leipzig Graduate School of Management

6/6/2009 OVARIAN CANCER

5/6/2009 NEW DRUG HOPE FOR ADVANCED MELANOMA

4/6/2009 CYTHERIS ANNOUNCES PUBLICATION OF PRECLINICAL STUDY IN NATURE MEDICINE

18/5/2009 SPECIM LAUNCHES RAMAN IMAGING SPECTROGRAPHS

7/5/2009 Overbrook Scientific will distribute Phytronix's laser diode thermal desorption ionization technology to labs in the US

5/5/2009 Merck Serono: Cladribine Tablets reduce relapse rate in patients with relapsing-remitting multiple sclerosis (MS).

5/5/2009 Report: Biomarkers in Alzheimer's Disease, 2009

4/5/2009 TEA AND HEALTH

30/4/2009 Mexican flu

28/4/2009 New vitamin E form isolated from kiwifruit

15/4/2009 PRESS RELEASE: Leipzig, April 14, 2009. Veterinary scientists join World Conference on Regenerative Medicine

15/4/2009 AMYLOIDOSIS

7/4/2009 Nerviano (MI). 630 researchers of Nerviano Medical Sciences (NMS) risk losing their job

30/3/2009 Arriva in Italia CYANOKIT®, antidoto di prima scelta nell’avvelenamento da cianuro

30/3/2009 Internazionalizzazione della ricerca, la rete fa la forza

23/3/2009 The ‘Paul P. Carbone Award in International Oncology 2009’ awarded to the Italian Giuseppe Masera

6/3/2009 Abiraterone Shows Activity in Hormone-Refractory Prostate Cancer

6/3/2009 FIDAXOMICIN (OPT-80): A NOVEL MACROCYCLE WITH AN EXCELLENT ACTIVITY AGAINST CLOSTRIDIO

28/2/2009 BioSquare, the biotechnologies business event Lyon, France

25/2/2009 EUROPEAN COMMISSION APPROVES PRASUGREL EFIENT FOR ACUTE CORONARY SYNDROME

24/2/2009 Kinaxo contributes its quantitative phosphoproteomics platform to a drug efficiency study

12/2/2009 FDA APPROVES CLINICAL STUDIES OF A NOVEL ANTI-CANCER DRUG, CDC7 INHIBITOR, DEVELOPED BY ITALIAN RESEARCHERS

12/2/2009 ANTI-TUMOR VACCINATION: STATE OF THE ART IN 2008

12/2/2009 PRILIGY™ (DAPOXETINE) RECEIVES FIRST REGULATORY APPROVALS FOR THE TREATMENT OF PREMATURE EJACULATION (PE) IN FINLAND AND SWEDEN

4/2/2009 MULTIPLE SCLEROSIS: SIGNIFICANTLY REDUCED RELAPSE RATE WITH ORAL CLADRIBINE

2/2/2009 FDA Approves Epiduo Gel for the topical treatment of acne vulgaris.

30/1/2009 ALCOHOLISM: LOOKING AHEAD OVER NALTREXONE

28/1/2009 FURTHER EVIDENCE TO THE ENHANCED EFFICACY OF CETUXIMAB IN METASTATIC COLORECTAL CANCER PATIENTS

17/1/2009 Galapagos selects pre-clinical candidate drug for cachexia

16/1/2009 BERRIES AND CANCER PREVENTION

12/1/2009 Immutep Announces Positive Interim Results in Phase I/II Chemoimmunotherapy Trial in Breast Cancer

16/12/2008 Merck Serono: European Commission Approves Cetuximab® for First-Line Use in Head and Neck Cancer

11/12/2008 Dipeptide blocks the formation of toxic amyloid β-peptide aggregates in mice

11/12/2008 COARTEM IS SAFE AND EFFECTIVE

11/12/2008 New England Journal of Medicine: Two new studies show malaria vaccine candidate advancing in Africa

10/12/2008 Accordo Pfizer Inc. e sigma-tau Industrie Farmaceutiche Riunite SpA

10/12/2008 DHA + PQP: A WINNER COMBINATION FOR NEW TREATMENT OF MALARIA

9/12/2008 A NEW PILL FOR TRANSIENT INSOMNIA AFTER SLEEP-TIME SHIFT: JET LAG

5/12/2008 LUMIGAN: A DRUG COULD HELP GROW EYELASHES

4/12/2008 FATE AND EFFECTS OF TAMIFLU IN THE ENVIRONMENT

1/12/2008 Biocitech

1/12/2008 95% OF THE BODY'S SUPPLY OF SEROTONIN IS PRODUCED IN THE GUT

18/11/2008 FDA Approves Banzel (rufinamide) as Adjunctive Treatment for Severe Epilepsy Disorder

10/11/2008 PURPLE TOMATOES AS POTENTIAL ANTICANCER

9/11/2008 FDA Approves Rapaflo® (Silodosin) for BPH

3/11/2008 Cytheris Initiates Clinical Trial of Interleukin-7 (IL-7) as an Immunotherapy in HCV Patients

28/10/2008 EFSA calls for more scientists

24/10/2008 Pharmaceutical Research in Italy continuing to experience difficulties

24/10/2008 JASCO’s New European Headquarter’s Grand Opening Concludes its 50th Anniversary Celebration in 2008

22/10/2008 Newly developed Geniom RT Analyzer form febit

17/10/2008 A Phase I clinical trial of ImmuFact IMP321 in pancreatic cancer will be carried out at Washington University in Saint Louis

15/10/2008 Europe's largest and most influential antibody event.

15/10/2008 New Safinamide patent granted by European Patent Office (EPO)

13/10/2008 SILODOSIN FOR SYMPTOMS OF BENIGN PROSTATIC HYPERPLASIA

9/10/2008 Awarded the Nobel Prize in Chemistry for 2008

8/10/2008 Nobel Prize in Physiology or Medicine, 2008

26/9/2008 REDUCTION OF OSTEOPOROSIS BY AN INVESTIGATIONAL MONOCLONAL ANTIBODY: DENOSUMAB

26/9/2008 Scandal in China: milk contaminated with melamina

26/9/2008 Nice Approves Pradaxa(R) - 1st New Oral Anticoagulant In UK For Over 50 Years

8/9/2008 FOCUS AND PERSPECTIVE ON THE ITALIAN BIOTECH PIPELINE.

31/8/2008 Class Of Diabetes Drugs Carries Significant Cardiovascular Risks

31/8/2008 Black raspberries slow cancer by altering hundreds of genes

26/7/2008 The new oral formulation of TNP-470 called LODAMINE offers potential non toxic cancer therapy or metastasis prevention.

15/7/2008 Honokiol, a natural compound from magnolia cones, blocks a pathway for cancer growth

9/7/2008 THE FIRST LUNG CANCER VACCINE TO BE APPROVED BY CUBAN AUTHORITIES

3/7/2008 Start of Phase II Clinical Study for Italian AIDS Vaccine

2/7/2008 HTI-286, A NEW POTENT TUBULIN INHIBITOR ACTIVE IN THE PROSTATE CANCER

27/6/2008 ARENEGYR: A new agent for the treatment of cancer

23/6/2008 ORAL AGENT SHOWS PROMISE AGAINST MULTIPLE SCLEROSIS

20/6/2008 Zoledronic Acid Significantly Reduced Relapse in Early Breast Cancer

20/6/2008 ASA404: A SMALL-MOLECULE TUMOR-VASCULAR DISRUPTING AGENT

18/6/2008 A “SERENDIPITOUS” APPROACH UNCOVERED A NEUROGENIC SMALL MOLECULE

10/6/2008 BRISTOL-MYERS SQUIBB AND ASTRA ZENECA DEMONSTRED SIGNIFICANT REDUCTION IN KEY MEASURES OF GLUCOSE CONTROL IN TREATMENT WITH ONGLYZA(TM) OF NAÏVE PEOPLE WITH TYPE 2 DIABETS.

4/6/2008 Synthetic molecules developed by Hebrew University researchers hold promise for new family of anti-cancer drugs

27/5/2008 TARGETED CANCER TERAPY: FROM TRIAL TO CLINICAL

19/5/2008 First EU licence granted for pre- pandemic bird flu vaccine

19/5/2008 NEW CANCER VACCINES IN DEVELOPMENT

19/5/2008 Prana Announces Completion of Phase IIa Trial of PBT2 in Alzheimer's Disease Patients

16/5/2008 DEBIOPHARM SIGNS LICENSE AGREEMENT FOR MARKETING OF SALVACYL®/MOAPAR 3-MONTH FOR SEXUAL DEVIATIONS

4/5/2008 INNOCENTIVE ANNOUNCED THE TOP SOLVERS 2007

3/5/2008 The U.S. FDA ACCEPTS ORITAVANCIN NDA (New Drug Application)

3/5/2008 AN EXTRAORDINARY STORY FROM DAILYMAIL

30/4/2008 ALBERT HOFMANN, FATHER OF LSD, DEAD AT 102

29/4/2008 FDA Approves Cimzia® to Treat Crohn's Disease

24/4/2008 CETIRIZINE HYDROCHLORIDE ORAL SOLUTION

10/4/2008 Winners for 2008 EFMC Awards announced

8/4/2008 NEW VACCINE TO PREVENT GASTROENTERITIS CAUSED BY ROTAVIRUS

6/4/2008 NEW DRUG APPLICATION FOR TREANDA(R) BY CEPHALON

28/3/2008 POSITIVE RESULTS OF AN2728 IN PSORIASIS PATIENTS

14/3/2008 FIRST THERAPY APPROVED FOR TREATMENT OF CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES (CAPS) A RARE, HEREDITARY, INFLAMMATORY DISEASE

13/3/2008 EMEA: STRONG PERFORMANCE IN 2007

13/3/2008 MULTIVITAMINS DO NOT REDUCE RISK FOR LUNG CANCER, AND VITAMIN E MAY RAISE IT

7/3/2008 Direct Thrombin Inhibitors: Alternatives to Heparin

7/3/2008 THE FDA APPROVED PRISTIQ FOR ANTIDEPRESSANT USE

7/3/2008 Cholesterol lowering mechanism of soybean protein hydrolysate identified

7/3/2008 U.S. REGULATORS IDENTIFIED CONTAMINANT IN BAXTER’S HEPARIN

11/2/2008 XELODA (CAPECITABINE) FOR TREATING METASTATIC COLORECTAL CANCER

11/2/2008 FROM INDUSTRY TO ACADEMIA

10/2/2008 INTELENCE™, A NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR, AGAINST HIV-1 INFECTION

7/2/2008 APPROUVED IN EUROPE THE NOVEL NOVARTIS’ ANTIDIABETES

1/2/2008 NEW RESEARCH: ALZHEIMERS PATIENTS IMPROVE DRAMATICALLY WITH ENBREL

31/1/2008 PHASE I STUDY OF AFP-464 IN PATIENTS WITH SOLID TUMORS

31/1/2008 NEW FDA ORPHAN DRUG FOR ORAL FLUDARABINE AGAINST CHRONIC LYMPHOCYTIC LEUKEMIA

24/1/2008 ELLAGITANNIN-RICH POMEGRANATE EXTRACT CAN INHIBIT ANGIOGENESIS IN PROSTATE CANCER IN VITRO AND IN VIVO

23/1/2008 “THE GOLDEN PILL 2007” TO AN ORPHAN DRUG

21/1/2008 DR. JUDAH FOLKMAN, M.D., U.S. CANCER PIONEER, DIES (1933-2008)

21/1/2008 HIGHER INTAKE OF CAROTENOIDS AND VITAMIN E COULD REDUCE THE RISK OF DEVELOPING CATARACT

11/1/2008 ONLY 19 NEW DRUGS APPROVED BY FDA IN 2007

10/1/2008 SUPER RED WINE MIGHT BOOST LIFESPAN

8/1/2008 THE NEW ANTI-FUNGAL DRUG ANIDULAFUNGIN NOW IN EU-COUNTRIES

4/1/2008 FAVORABLES RESULTS FROM FIRST CLINICAL TRIAL OF FV-100, AN ORAL DRUG FOR THE TREATMENT OF SHINGLES.

4/1/2008 TELBIVUDINE FOUND BETTER AT SUPPRESSING HEPATITIS B VIRUS.

4/1/2008 HYDROXYUREA CHEMOTHERAPY AGAINST MENINGIOMAS

3/1/2008 CORRELATION BETWEEN OF A NOVEL SMALL HEAT SHOCK PROTEIN (HSP16.2) AND MALIGNANCY IN BRAIN TUMORS

3/1/2008 Phase III Clinical Trial Program for ALTROPANE®

3/1/2008 SIGNAL TRANSDUCTION INHIBITORS IN CANCER THERAPY

19/12/2007 FDA APPROVED KUVAN™ AGAINST HIGH LEVEL OF BLOOD PHENYLALANINE

11/12/2007 NEW COMPOUNDS FOR PAIN TREATMENT

10/12/2007 HEPARANASE EXPRESSION CORRELATES WITH THE PROGRESSION OF TONGUE CANCER AND WITH TUMOR SIZE

5/12/2007 SBIO INITIATES CLINICAL TRIAL OF NOVEL ANTI-CANCER DRUG

1/12/2007 COSMO'S RIFAMYCIN SV MMX™ MEETS CLINICAL ENDPOINTS IN PHASE II TRIAL FOR INFECTIOUS DIARRHOEA

26/11/2007 MONEY FOR BIOMEDICAL RESEARCH

24/11/2007 NEW ORPHAN DRUGS: AVI-4658, SQ109, ATIR

21/11/2007 Overcoming adversity, one drug at a time

20/11/2007 TREATMENT OF SCHIZOPHRENIA WITH SEROQUEL XR(TM) ADMINISTERED ONCE DAILY

13/11/2007 GALENO 2007: THE WINNER IS TIGECYCLINE

11/11/2007 TOPOTECAN HYDROCHLORIDE (HYCAMTIN®) FOR ORAL USE.

11/11/2007 APPROVED BY THE US FDA TASIGNA® (NILOTINIB) FOR THE TREATMENT OF CML

7/11/2007 COMBIGAN, A WINNER COMBINATION FOR REDUCTION OF INTRAOCULAR PRESSURE IN PATIENTS WITH GLAUCOMA OR OCULAR HYPERTENSION

28/10/2007 FDA APPROVES IXEMPRA (IXABEPILONE), FOR ADVANCED BREAST CANCER PATIENTS

28/10/2007 ISENTRESS® (RALTEGRAVIR) FOR THE TREATMENT OF HIV-1 STRAINS RESISTENT INFECTIONS

28/10/2007 DORIBAX(R) (DORIPENEM), A NOVEL PENEM ANTIBACTERIAL

18/10/2007 AGREEMENT BETWEEN GLAXOSMITHKLINE AND SYNTA PHARMA FOR A NOVEL ANTIMELANOMA DRUG STA-4783

18/10/2007 NEW FDA ORPHAN DRUG MB07133 FOR THE TREATMENT OF LIVER CANCER

11/10/2007 NEW FDA ORPHAN DRUG: IPI-504 FOR GASTROINTESTINAL STROMAL TUMORS

10/10/2007 THE NOBEL PRIZE IN CHEMISTRY 2007

10/10/2007 TANESPIMYCIN, THE FIRST HSP90 INHIBITOR TO ENTER A REGISTRATION PROGRAM.

9/10/2007 THE NOBEL PRIZE IN PHYSIOLOGY OR MEDICINE 2007

6/10/2007 FDA APPROVES NEW DRUG TO TREAT RARE DISEASE, ACROMEGALY

1/10/2007 FDA FAST TRACKS ANTI-CANCER PROGEN’S PI-88

28/9/2007 RECORDATI COMPLETES THE SILODOSIN PHASE III CLINICAL TRIALS

21/9/2007 OSTEOPOROSIS DRUG SUCCEEDS IN 3 YEARS STUDY

17/9/2007 FDA APPROVES LILLY'S OSTEOPOROSIS DRUG EVISTA(TM)

17/9/2007 POSITIVE REPORTS FROM PHASE II CLINICAL TRIALS ON ANTIFLAMMATORY TPI-1020

17/9/2007 LOOK AT JUICE

14/9/2007 ISENTRESS : A NOVEL ANTI-HIV APPROVED BY THE FDA

14/9/2007 PIXANTRONE, A NOVEL ANTHRACYCLINE

13/9/2007 EARLY DIAGNOSIS OF METASTASIS

5/9/2007 ELI LILLY OPENS DOOR FOR NEXT-GENERATION ANTIPSYCHOTICS

3/9/2007 CLOBUTINOL: AFTER 46 YEARS BANNED THE USE OF COUGH MEDICINES BECAUSE OF A POTENTIAL RISK OF IRREGULAR HEART BEAT

2/9/2007 BIOLOGICAL SCIENCES ON LINE

31/8/2007 TOTAL SYNTHESIS OF AZADIRACHTIN ACHIEVED

27/8/2007 THE FUTURE OF THE NOVEL DRUG FOR THE TREATMENT OF MALIGNANT MESOTELIOMA

21/8/2007 SANCTURA®, A MUSCARINIC RECEPTOR ANTAGONISTS FOR THE OVERACTIVE BLADDER

20/8/2007 PIVOTAL PHASE II CLINICAL TRIAL WITH TAMIBAROTENE IN REFRACTORY ACUTE PROMYELOCYTIC LEUKEMIA

19/8/2007 PI-88 FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA

18/8/2007 FDA APPROVES SELZENTRY™ FOR THE TREATMENT OF HIV

2/8/2007 ABIRATERONE SHOWS PROMISE IN HORMONE-REFRACTIVE PROSTATE CANCER

2/8/2007 SPECTRUM PHARMACEUTICALS ACQUIRES FROM INDENA WORLDWIDE RIGHTS TO ORTATAXEL

2/8/2007 INITIATES PHASE I CLINICAL TRIAL A NOVEL HSP27 INHIBITOR

31/7/2007 TARGACEPT INC. INITIATES PHASE I CLINICAL TRIAL OF TC-5619

30/7/2007 GENAERA CORP. PRESENTS NEW PRECLINICAL DATA FOR OBESITY COMPOUND TRODUSQUEMINE (MSI-1436) AT CBI CONFERENCE

30/7/2007 NEW TARGET FOR HIV/AIDS DRUGS AND VACCINE DISCOVERED

24/7/2007 FDA APPROVES SCHWARZ PHARMA'S NEUPRO(R) - ROTIGONINE TRANSDERMAL SYSTEM - FOR THE TREATMENT OF EARLY-STAGE PARKINSON’S DISEASE IN USA.

23/7/2007 IMI: EVERYTHING READY IN ORDER TO START AT BEGINNING 2008

22/7/2007 EUROPEAN TRADITIONAL MEDICINES - INTERNAZIONAL CONGRESS

13/7/2007 A SYNERGIC EFFECT OF A TLR9 AGONIST AND BEVACIZUMAB IN TUMOR RESISTANT TO ANTI-EGFR DRUGS

13/7/2007 SUCCESS OF THE STRATEGIC US-ITALIAN COOPERATION TO FIGHT OVARIAN CANCER

10/7/2007 EFSA AND FDA STRENGTHEN COOPERATION IN FOOD SAFETY SCIENCE

8/7/2007 A NEW MOLECULE FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION

8/7/2007 FDA APPROVES ALISKIREN: FIRST NEW ANTIHYPERTENSIVE ON THE MARKET IN MORE THAN 10 YEARS

8/7/2007 PFIZER’S LYRICA RECEIVES FDA APPROVAL FOR FIBROMYALGIA

8/7/2007 EXENATIDE: A NEW TYPE OF DRUG FOR TYPE 2 DIABETES NOW IN ITALY

3/7/2007 MEDITERRANEAN DIET ENRICHED WITH WALNUTS ALSO PROTECTS AGAINST OXIDATIVE DAMAGE

28/6/2007 ADDING FOLIC ACID TO BREAD COULD HELP IN THE FIGHT OF DEPRESSION

26/6/2007 NIKEM RESEARCH SRL ENTERS INTO RESEARCH SERVICE AGREEMENT WITH INTERMUNE INC.

21/6/2007 FDA APPROVES COMMERCIALIZATION OF DIFFERIN ® (ADAPALENE) GEL 0.3% FOR ACNE

21/6/2007 ITALIAN EURAND’S ZENTASE™ EFFECTIVE IN TREATING EXOCRINE PANCREATIC INSUFFICIENCY, STUDIES SHOW

21/6/2007 FDA GRANTS “PRIORITY REVIEW” FOR BRISTOL MAYER SQUIBB COMPANY INVESTIGATIONAL ONCOLOGY TREATMENT IXABEPILONE.

21/6/2007 SHIRE PHARMACEUTICAL IN-LICENSES JUVISTAR ® (HUMAN TGFbeta3) FROM RENOVO

17/6/2007 OMACOR®: THE FIRST AND ONLY FDA-APPROVED PRESCRIPTION OMEGA-3 FATTY ACID PRODUCT

16/6/2007 ENCYCLOPEDIA OF DNA ELEMENTS (ENCODE) CONSORTIUM

15/6/2007 GENE THERAPY AND STEM CELLS: A MEETING FOR NEW CHANCES IN CLINICAL TRIALS

12/6/2007 CANCER STEM CELLS: AN INTERESTING REVIEW

11/6/2007 POINT OUT ON AN INTERESTING REVIEW BY E. Weisberg et al..

10/6/2007 SATISFIED OR REFUNDED

10/6/2007 THE SEA SPONGES HIDE THE SECRET OF THE NERVOUS SYSTEM OF THE MAN

4/6/2007 FDA Approves Torisel, an mTOR Inhibitor

4/6/2007 POST-MARKETING STUDIES

4/6/2007 TO ASSIST SMOKERS IN SMOKING CESSATION

28/5/2007 NEW DRUG APPROVED BY FDA TO TREAT VAGINAL INFECTIONS<

27/5/2007 THE PHARMACEUTICAL INDUSTRY WOULD FUND “PHARMA TV”

26/5/2007 ROTIGOTINE IS A NON-ERGOLINE FOR THE TREATMENT OF PARKINSON’S DISEASE

26/5/2007 FDA APPROVES CONTRACEPTIVE FOR CONTINUOUS USE

20/5/2007 TUMORS: TO IRANIAN MINE BISSELL PRIZE PEZCOLLER 2007

10/5/2007 NEW BMS ANTITHROMBOTIC MOLECULE : ENCOURAGING DATA FROM PHASE II STUDIES

7/5/2007 LYBREL: WAITING FOR A FDA’S DECISION

4/5/2007 VR004 (APOMORPHINE): A SILDENAFIL (VIAGRA®) ALTERNATIVE

4/5/2007 EUROPEAN INVENTION OF THE YEAR AWARD

3/5/2007 DANISH BIOTECH OCCUPIES 3rd POSITION IN EUROPE

3/5/2007 FDA NEWSa ABOUT GENERIC DRUGS DEVELOPMENT:

21/4/2007 NEW DRUGS CLASSIFICATION

20/4/2007 AACR. The Centennial edition (1907-2007)

17/4/2007 NICOX AND PFIZER ALL TOGHETER IN PHASE II WITH PF-03187207 A NEW MOLECULE ANTIGLAUCOMA

17/4/2007 GSK ANNOUNCES FDA APPROVAL Of AlLTABAX™ (RETAPAMULIN)

17/4/2007 NEW BULLET TO FIGHT CANCER MOVES FORWARD TO PHASE III

4/4/2007 FAST TRACK DESIGNATION TO ALZHEIMER'S DISEASE DRUG CANDIDATE AZD-103/ELND005

31/3/2007 The effect of Boswellia Serrata extract on reliving osteoarthritis pain compared to the effect of the selective COX-2 inhibitor Valdecoxib

30/3/2007 Cancer therapy: When all else fails why don’t try!

24/3/2007 A NEW MOLECULAR ENTITY (NME) IN BREAST CANCER

20/3/2007 UNIVERSITY OF MODENA TO HEAD RESEARCH OF NOVEL ANTITUMOUR AGENTS

18/3/2007 IN THE PLANTS A VACCINE THERAPEUTIC AGAINST HPV

16/3/2007 CONTINUOUS THE FINDING TO SPECIFIC VACCINE IN THE FIGHT AGAINST THE CANCER

15/3/2007 STARTED PATIENT DOSING IN L-ANNAMYCIN PHASE I CLINICAL TRIAL

9/3/2007 FDA APPROVES VYVANSE™, A PRO-DRUG OF AMPHETAMINE

8/3/2007 BACK TO THE FUTURE

7/3/2007 A NOVEL ANTIHYPERTENSIVE AGENTS FROM NOVARTIS PHARMS

5/3/2007 SNS-314: FILES INVESTIGATIONAL NEW DRUG APPLICATION FOR NOVEL AURORA KINASE INHIBITOR

26/2/2007 THE NEW HORIZONS OF THE MEDICINE

25/2/2007 DRUG DEPOT IN A TOOTH

23/2/2007 PREGNANCY HORMONE REVERSES MS DAMAGE

20/2/2007 A NEW FDA APPROVED ONCE-A-DAILY MUSCLE RELAXANT

19/2/2007 SIGNED AGREEMENT BETWEEN SCI & WWF

18/2/2007 SATRAPLATIN USEFUL AGAINST PROSTAT CANCER

16/2/2007 ALCOHOL TEST DETECT IF STUDENTS HAVE BEEN DRINKING.

14/2/2007 DECAPEPTIDE FROM DURUM WHEAT PREVENTS CELIAC PERIPHERAL BLOOD LYMPHOCYTES FROM ACTIVATION BY GLIADIN PEPTIDES.

8/2/2007 FDA APPROVES NEW BREAST CANCER TEST

5/2/2007 A YEAR AFTER THE FDA APPROVATION OF A NEW TREATMENT FOR GASTROINTESTINAL AND KIDNEY CANCER

4/2/2007 FDA APPROVED AN EXTENDED-RELEASE TABLETS OF LOVASTATIN (ALTOPREV™)

30/1/2007 GUIDELINES ON PHARMACOVIGILANCE FOR MEDICINAL PRODUCTS FOR HUMAN AND VETERINARIAN USE

30/1/2007 INSULIN PILL ONE

29/1/2007 TUMOR REGRESSION THROUGH A REACTIVATION OF P53 TUMOR SUPPRESSOR GENE

29/1/2007 PROPHYLAXIS OF ASPERGILLUS AND CANDIDA INFECTIONS WITH POSACONAZOLE (NOXAFIL®)

29/1/2007 ZEN-012: A NOVEL HIGHLY POTENT ORALLY ACTIVE MULTI-TARGETED CYTOTOXIC COMPOUND

24/1/2007 RENAL CANCER – POSSIBLE THERAPEUTIC APPROACHES: SUNITINIB & SORAFENIB: SOME DIFFERENCES, & COMPETITION

18/1/2007 FDA APPROVES SLENTROL® - THE FIRST DRUG FOR OBESE DOGS

14/1/2007 HOMING NANOPARTICLES PACK MULTIPLE ASSAULT ON TUMORS

14/1/2007 FROM THE BIOMIRA CANADIAN THE FIRST VACCINE FOR LUNG CANCER

10/1/2007 POSITIVE PHASE 2 RESULTS FOR NOVEL SLEEP DRUG - HY10275

8/1/2007 RECORDATI HAS SIGNED A NON-EXCLUSIVE AGREEMENT WITH SIGMA-TAU

2/1/2007 IVABRADINE (PROCORALAN - Servier Italia and CORLENTOR -I.F.B. Stroder), THE FIRST PURE HEART RATE–LOWERING AGENT.

2/1/2007 PHARMACYCLICS SUBMITS NEW DRUG APPLICATION FOR XCYTRIN(TM) FOR THE TREATMENT OF LUNG CANCER BRAIN METASTASES

28/12/2006 CURCUMIN & ALZHEIMER'S DISEASE

27/12/2006 IDENTIFIED A MECHANISM BY WHICH CHECKPOINT KINASES REGULATE RESPONSES TO DNA DAMAGE

27/12/2006 IDENTIFIED A PROTEIN GROUP INVOLVED IN THE DUPLICATION OF GENOME DURING CELL DIVISION

18/12/2006 In vitro and In vivo Activity of SKI-606 against Imatinib-Resistant Neoplastic Cells

6/12/2006 ITALIAN-CHINESE NEW ANTIMALARIAL DRUG

3/12/2006 THE FIRST HDAC INHIBITOR APPROVAL FROM FDA

30/11/2006 GARDASIL, A NEW PROMISING VACCINE AGAINST CERVICAL CANCER

24/11/2006 A NEW DRUG FOR SMOKING CESSATION NOW AVAILABLE

13/11/2006 MASTER IN DRUG DESIGN AND SYNTHESIS

12/11/2006 100 YEARS OF ALZHEIMER'S DISEASE

12/11/2006 THE PROTEIN THAT CAUSE A PHYSIOLOGICAL IMPACT OF AGEING IDENTIFIED

12/11/2006 SAFINAMIDE - a potent anticonvulsant and antiparkinsonian drug

11/11/2006 RESVERATROL IMPROVES HEALTH AND SURVIVAL OF OVERWEIGHT MALE MICE

6/11/2006 FDA APPROVES NEW TREATMENT FOR DIABETES

3/11/2006 COULD SUMO REPRESENT A POTENTIAL NEW DRUG TARGET?

3/11/2006 Adjudin: a male contraceptive drug is a step closer to pharmacy shelves

30/10/2006 FDA APPROVED TYZEKA™ FOR TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS B

25/10/2006 Towards FP7 (Framework Programme 7)

24/10/2006 HUMIRA® (ADALIMUMAB) RECEIVES FDA APPROVAL FOR TREATMENT OF ANKYLOSING SPONDYLITIS

24/10/2006 FINGOLIMOD SHOWS POSITIVE RESULTS IN PHASE II TRIALS

15/10/2006 FDA GRANTS FAST TRACK STATUS TO R1626

11/10/2006 DAILY SUPPLEMENTS OF THE FRENCH MARITIME PINE BARK EXTRACT, COULD IMPROVE BLOOD FLOW IN DIABETIC MICROANGIOPATHY

6/10/2006 HYPOTHESIZED A NEW MECHANISM FOR EVOLUTION OF CELLS THAT LEAD TO ALZHEIMER’S DISEASE

6/10/2006 THE NOBEL PRIZE IN PHYSIOLOGY OR MEDICINE FOR 2006 AWARDED TO ANDREW Z. FIRE AND CRAIG C. MELLO

5/10/2006 THE NOBEL PRIZE IN CHEMISTRY FOR 2006 AWARDED TO ROGER D. KORNBERG

1/10/2006 DAPOXETINE HYDROCHLORIDE & PREMATURE EJACULATION

1/10/2006 ALZHEIMER'S DRUG ALSO COMBATS BRAIN INJURIES

19/9/2006 ONCOLOGY RESEARCHERS RECOGNIZED AS HEROES OF CHEMISTRY

11/9/2006 IN EUROPE, R&D OUTSOURCING DOMINATED BY PHARMA AND BIOTECH

9/9/2006 CHINESE BIRD FLU VACCINE SHOWS BEST RESULTS YET

7/9/2006 FDA APPROVES NEW DRUG FOR HIV TREATMENT